Sagent Pharmaceuticals, Inc. Pays $25 Million to Buy Out China JV Partner

by Richard Daverman, PhD

May 6, 2013 -- Sagent Pharmaceuticals, a Chicago-area maker of generic injectable drugs, will acquire its partner’s 50% interest in a China JV for $25 million. Chengdu Kanghong Pharmaceuticals owned the other half of the JV, which was established in 2006 to build an FDA/GMP compliant manufacturing facility. Sagent apparently expects to use the China facility to manufacture products that supply the China and US markets. More details....

Stock Symbol: (NSDQ: SGNT)